New DRX-L Detector for Long-Length Digital Radiography Is Launched: Reports Carestream Health

Device Uses Multiple Sensors to Capture High-Resolution Images in Seconds; Single Exposure Improves Workflow While Reducing Dose

Carestream Health has introduced a new digital radiography detector in the United States and Canada, enabling hospitals and imaging centers that specialize in long-length imaging to increase productivity while decreasing both patient discomfort and dose.

Carestream Health notes with a single exposure, the CARESTREAM DRX-L Detector captures long-length images by providing a large field of view and high resolution for leg-length and spine exams. Since the image is acquired in one exposure, it decreases dose and overall exam time as compared to examinations that require multiple exposures. This approach minimizes discomfort by reducing the time that a patient needs to remain still.

“The new DRX-L Detector captures the entire long-length image dimensions—whether imaging the spine, performing a scoliosis exam or a hip-to-heel exam—with one single shot and one single exposure,” said Jill Hamman, Worldwide Marketing Manager at Carestream. “With traditional multi-shot digital radiography and multiple detectors, the technologist has to take separate shots to image the entire spine. That takes more set-up time as well as exam time.”

This can pose a challenge for patients with limited mobility or a pediatric patient with scoliosis who finds it challenging to be still. “When it’s very difficult for a patient to stand still or for any patient who is uncomfortable and in pain, even 15 seconds of capturing multiple diagnostic images can feel like an hour,” Ms. Hamman said.

A single-shot acquisition also minimizes the need for retakes and eliminates the need for the image to be manipulated and stitched due to patient movement. The DRX-L Detector uses Carestream’s ImageView Software with Eclipse Image Processing for high image quality and provides one unified image, without the need for modification. This detector also features the X-Factor, which means it can be shared with other compatible DRX equipment.

The DRX-L Detector supports a wide array of Carestream digital X-ray products, including:

“This detector will allow facilities to conduct critical long-length exams efficiently and seamlessly while delivering the highest level of care with imaging, diagnosing and treatment planning for patients,” Ms. Hamman added.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides our readership with breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

LumiGuide, powered by Fiber Optic RealShape (FORS) technology, enables doctors to navigate through blood vessels using light, instead of X- ray. “[It’s] one of the most exciting changes that we’ve seen with imaging certainly throughout my career,” said Andres Schanzer, Vascular Surgeon, at UMass Memorial Medical Center, Worcester, MA, USA.
Carestream Health notes twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.
According to an Insightec study, patients experienced significant reductions in upper limb tremor, tremor-related disability, and quality of life. The most common intraprocedural adverse events included dizziness, headache, nausea, and vomiting, which all resolved. Post-procedural adverse events included paraesthesia and gait disturbance, which were often transient or resolved within 12 months.
Chris Landon, Business Leader Image Guided Therapy Devices at Philips: “IVUS is a technology that has demonstrated an ability to both support safer procedures for patients and procedural staff alike including reductions in radiation exposure. As the global leader in IVUS solutions, we are grateful for the rigorous multidisciplinary approach to developing expert consensus on the value of IVUS and we look forward to working with all stakeholders to standardize the use of IVUS and reduce the barriers preventing utilization.”
"We are delighted to see our 3D solution CE-marked and available on the European market," says Ulrik Harrysson, CEO at SyntheticMR AB. "SyMRI 3D represents the next generation of quantitative MRI, offering unprecedented resolution and accuracy in brain imaging, revolutionizing the landscape of medical diagnostics."

By using this website you agree to accept Medical Device News Magazine Privacy Policy